<DOC>
	<DOCNO>NCT02050802</DOCNO>
	<brief_summary>The study intend demonstrate macitentan effect cardiac repolarization exceed threshold regulatory concern repeat administration daily oral dos 10 30 mg healthy male female subject .</brief_summary>
	<brief_title>Study Assess Effect Macitentan Electrocardiogram ( ECG ) Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Macitentan</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Ability communicate well investigator local language , understand comply requirement study . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation . Males female age ≥ 18 ≤ 55 year screen . Women childbearing potential must negative pretreatment serum pregnancy test use consistently correctly 2 method contraception time screen 30 day study treatment discontinuation . Abstinence consider reliable method contraception . Healthy basis medical history assessment perform screen . Physical examination without clinically relevant abnormality screen . Body mass index ( BMI ) ≥ 18.0 ≤ 28.0 kg/m^2 screening . Body weight least 50.0 kg . Negative result urine drug screen alcohol test screening . Willing able refrain alcohol consumption study start end study . Negative human immunodeficiency virus ( HIV ) serology hepatitis serology screen . Systolic blood pressure ( SBP ) 100145 mmHg , diastolic blood pressure ( DBP ) 5090 mmHg , heart rate ( HR ) 4590 bpm ( inclusive ) , measure dominant arm ( dominant arm = write arm ) . 12lead ECG without clinically relevant abnormality screen Day 1 prior drug administration . Hematology , blood chemistry , urinalysis result deviate normal range clinically relevant extent screen Day 1 prior drug administration . Known hypersensitivity excipients drug formulation . Treatment macitentan another investigational drug 3 month prior screen . History clinical evidence disease and/or existence surgical medical condition , might interfere absorption , distribution , metabolism , excretion macitentan moxifloxacin ( except appendectomy herniotomy ) . History clinical evidence drug abuse , alcoholism , psychiatric disease within 3 year period prior screen . Caffeine consumption ≥ 800 mg per day screening . History fainting , collapse , syncope , blackout , orthostatic hypotension , vasovagal reaction . Chronic relevant acute infection . History relevant allergy/hypersensitivity . Previous treatment prescribe overthecounter medication herbal remedy ( include herbal medicine St John 's Wort ) within 2 week prior first dose trial . Smoking use tobacco substitute nicotine substitute . Loss 250 mL blood 3 month prior dose ( include blood donation ) . Positive result hepatitis serology screening , except vaccinated subject . Aspartate aminotransferase ( AST ) and/or alanine aminotransferase ( ALT ) upper limit normal prior randomization . Excessive physical activity within 1 week prior randomization . Any cardiac condition ( include ECG abnormality ) illness potential increase cardiac risk subject might affect correct QT analysis ( QTc ) . QTc &gt; 450 m &gt; 470 m ( use ECG machine heart ratecorrection method ) randomization male female subject , respectively . Subjects personal family history longQT syndrome hypokalemia . Legal incapacity limit legal capacity screening . Veins unsuitable intravenous ( i.v . ) puncture either arm ( e.g. , vein difficult locate , access puncture ; vein tendency rupture puncture ) . Vulnerable subject ( e.g. , person keep detention ) . Employee investigator study center , direct involvement propose study study direction investigator study center , well family member employee investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Macitentan</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>